PRICE INQUIRY no. NUSI/62/PR49446/2024 - being conducted as a market assessment study
In connection with the implementation of the project titled „Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, financed from the state budget funds from the Medical Research Agency, Zakłady Farmaceutyczne „Polpharma” S.A., requests that you submit bids for the purchase and supply of reference drug SPINRAZA.
Details of the price inquiry can be found in the documents attached below.
go back